[(1R,6S,8S,9R,10S,11R,16S,18R,19R)-9-(6-aminopurin-9-yl)-10-hydroxy-19-(hydroxymethyl)-18-(2-methyl-6-oxo-1H-purin-9-yl)-3,13-dioxo-3-(propan-2-yloxycarbonyloxymethoxy)-2,4,12,14,17-pentaoxa-3λ5,13λ5-diphosphatetracyclo[14.2.1.06,8.06,11]nonadecan-13-yl]sulfanylmethyl propan-2-yl carbonate

C34H45N9O17P2S — CID 158858553

IUPAC[(1R,6S,8S,9R,10S,11R,16S,18R,19R)-9-(6-aminopurin-9-yl)-10-hydroxy-19-(hydroxymethyl)-18-(2-methyl-6-oxo-1H-purin-9-yl)-3,13-dioxo-3-(propan-2-yloxycarbonyloxymethoxy)-2,4,12,14,17-pentaoxa-3λ5,13λ5-diphosphatetracyclo[14.2.1.06,8.06,11]nonadecan-13-yl]sulfanylmethyl propan-2-yl carbonate
SMILESCc1nc2c(ncn2[C@@H]2O[C@@H]3COP(=O)(SCOC(=O)OC(C)C)O[C@H]4[C@@H](O)[C@H](n5cnc6c(N)ncnc65)[C@H]5C[C@@]54COP(=O)(OCOC(=O)OC(C)C)O[C@@H]2[C@@H]3CO)c(=O)[nH]1
InChIInChI=1S/C34H45N9O17P2S/c1-15(2)56-32(47)51-13-55-61(49)54-9-34-6-19(34)23(42-11-38-21-27(35)36-10-37-28(21)42)24(45)26(34)60-62(50,63-14-52-33(48)57-16(3)4)53-8-20-18(7-44)25(59-61)31(58-20)43-12-39-22-29(43)40-17(5)41-30(22)46/h10-12,15-16,18-20,23-26,31,44-45H,6-9,13-14H2,1-5H3,(H2,35,36,37)(H,40,41,46)/t18-,19-,20-,23-,24+,25-,26+,31-,34-,61?,62?/m1/s1
InChIKeyQXRVVMRQZZBBEC-VHFJMBKNSA-N
MW945.79 g/mol
LogP3.10
Rot. Bonds11

About [(1R,6S,8S,9R,10S,11R,16S,18R,19R)-9-(6-aminopurin-9-yl)-10-hydroxy-19-(hydroxymethyl)-18-(2-methyl-6-oxo-1H-purin-9-yl)-3,13-dioxo-3-(propan-2-yloxycarbonyloxymethoxy)-2,4,12,14,17-pentaoxa-3λ5,13λ5-diphosphatetracyclo[14.2.1.06,8.06,11]nonadecan-13-yl]sulfanylmethyl propan-2-yl carbonate

[(1R,6S,8S,9R,10S,11R,16S,18R,19R)-9-(6-aminopurin-9-yl)-10-hydroxy-19-(hydroxymethyl)-18-(2-methyl-6-oxo-1H-purin-9-yl)-3,13-dioxo-3-(propan-2-yloxycarbonyloxymethoxy)-2,4,12,14,17-pentaoxa-3λ5,13λ5-diphosphatetracyclo[14.2.1.06,8.06,11]nonadecan-13-yl]sulfanylmethyl propan-2-yl carbonate (PubChem CID 158858553) has the molecular formula C34H45N9O17P2S and a molecular weight of 945.79 g/mol. Its IUPAC name is [(1R,6S,8S,9R,10S,11R,16S,18R,19R)-9-(6-aminopurin-9-yl)-10-hydroxy-19-(hydroxymethyl)-18-(2-methyl-6-oxo-1H-purin-9-yl)-3,13-dioxo-3-(propan-2-yloxycarbonyloxymethoxy)-2,4,12,14,17-pentaoxa-3λ5,13λ5-diphosphatetracyclo[14.2.1.06,8.06,11]nonadecan-13-yl]sulfanylmethyl propan-2-yl carbonate.

Molecular Properties

Compound Name[(1R,6S,8S,9R,10S,11R,16S,18R,19R)-9-(6-aminopurin-9-yl)-10-hydroxy-19-(hydroxymethyl)-18-(2-methyl-6-oxo-1H-purin-9-yl)-3,13-dioxo-3-(propan-2-yloxycarbonyloxymethoxy)-2,4,12,14,17-pentaoxa-3λ5,13λ5-diphosphatetracyclo[14.2.1.06,8.06,11]nonadecan-13-yl]sulfanylmethyl propan-2-yl carbonate
PubChem CID158858553
Molecular FormulaC34H45N9O17P2S
Molecular Weight945.79 g/mol
Exact Mass945.21
IUPAC Name[(1R,6S,8S,9R,10S,11R,16S,18R,19R)-9-(6-aminopurin-9-yl)-10-hydroxy-19-(hydroxymethyl)-18-(2-methyl-6-oxo-1H-purin-9-yl)-3,13-dioxo-3-(propan-2-yloxycarbonyloxymethoxy)-2,4,12,14,17-pentaoxa-3λ5,13λ5-diphosphatetracyclo[14.2.1.06,8.06,11]nonadecan-13-yl]sulfanylmethyl propan-2-yl carbonate
SMILESCc1nc2c(ncn2[C@@H]2O[C@@H]3COP(=O)(SCOC(=O)OC(C)C)O[C@H]4[C@@H](O)[C@H](n5cnc6c(N)ncnc65)[C@H]5C[C@@]54COP(=O)(OCOC(=O)OC(C)C)O[C@@H]2[C@@H]3CO)c(=O)[nH]1
InChIInChI=1S/C34H45N9O17P2S/c1-15(2)56-32(47)51-13-55-61(49)54-9-34-6-19(34)23(42-11-38-21-27(35)36-10-37-28(21)42)24(45)26(34)60-62(50,63-14-52-33(48)57-16(3)4)53-8-20-18(7-44)25(59-61)31(58-20)43-12-39-22-29(43)40-17(5)41-30(22)46/h10-12,15-16,18-20,23-26,31,44-45H,6-9,13-14H2,1-5H3,(H2,35,36,37)(H,40,41,46)/t18-,19-,20-,23-,24+,25-,26+,31-,34-,61?,62?/m1/s1
InChIKeyQXRVVMRQZZBBEC-VHFJMBKNSA-N
XLogP3.10
TPSA334.23 Ų
H-Bond Donors4
H-Bond Acceptors26
Rotatable Bonds11
Heavy Atoms63
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500945.79
LogP ≤ 53.10
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 1026

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'het-C-het_not_in_ring', 'substructure': 'N/A'}, {'alert_name': 'phosphor', 'substructure': 'N/A'}

Analyze [(1R,6S,8S,9R,10S,11R,16S,18R,19R)-9-(6-aminopurin-9-yl)-10-hydroxy-19-(hydroxymethyl)-18-(2-methyl-6-oxo-1H-purin-9-yl)-3,13-dioxo-3-(propan-2-yloxycarbonyloxymethoxy)-2,4,12,14,17-pentaoxa-3λ5,13λ5-diphosphatetracyclo[14.2.1.06,8.06,11]nonadecan-13-yl]sulfanylmethyl propan-2-yl carbonate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of [(1R,6S,8S,9R,10S,11R,16S,18R,19R)-9-(6-aminopurin-9-yl)-10-hydroxy-19-(hydroxymethyl)-18-(2-methyl-6-oxo-1H-purin-9-yl)-3,13-dioxo-3-(propan-2-yloxycarbonyloxymethoxy)-2,4,12,14,17-pentaoxa-3λ5,13λ5-diphosphatetracyclo[14.2.1.06,8.06,11]nonadecan-13-yl]sulfanylmethyl propan-2-yl carbonate?
The IUPAC name of [(1R,6S,8S,9R,10S,11R,16S,18R,19R)-9-(6-aminopurin-9-yl)-10-hydroxy-19-(hydroxymethyl)-18-(2-methyl-6-oxo-1H-purin-9-yl)-3,13-dioxo-3-(propan-2-yloxycarbonyloxymethoxy)-2,4,12,14,17-pentaoxa-3λ5,13λ5-diphosphatetracyclo[14.2.1.06,8.06,11]nonadecan-13-yl]sulfanylmethyl propan-2-yl carbonate (CID 158858553) is [(1R,6S,8S,9R,10S,11R,16S,18R,19R)-9-(6-aminopurin-9-yl)-10-hydroxy-19-(hydroxymethyl)-18-(2-methyl-6-oxo-1H-purin-9-yl)-3,13-dioxo-3-(propan-2-yloxycarbonyloxymethoxy)-2,4,12,14,17-pentaoxa-3λ5,13λ5-diphosphatetracyclo[14.2.1.06,8.06,11]nonadecan-13-yl]sulfanylmethyl propan-2-yl carbonate.
What is the SMILES notation for [(1R,6S,8S,9R,10S,11R,16S,18R,19R)-9-(6-aminopurin-9-yl)-10-hydroxy-19-(hydroxymethyl)-18-(2-methyl-6-oxo-1H-purin-9-yl)-3,13-dioxo-3-(propan-2-yloxycarbonyloxymethoxy)-2,4,12,14,17-pentaoxa-3λ5,13λ5-diphosphatetracyclo[14.2.1.06,8.06,11]nonadecan-13-yl]sulfanylmethyl propan-2-yl carbonate?
The canonical SMILES for [(1R,6S,8S,9R,10S,11R,16S,18R,19R)-9-(6-aminopurin-9-yl)-10-hydroxy-19-(hydroxymethyl)-18-(2-methyl-6-oxo-1H-purin-9-yl)-3,13-dioxo-3-(propan-2-yloxycarbonyloxymethoxy)-2,4,12,14,17-pentaoxa-3λ5,13λ5-diphosphatetracyclo[14.2.1.06,8.06,11]nonadecan-13-yl]sulfanylmethyl propan-2-yl carbonate is Cc1nc2c(ncn2[C@@H]2O[C@@H]3COP(=O)(SCOC(=O)OC(C)C)O[C@H]4[C@@H](O)[C@H](n5cnc6c(N)ncnc65)[C@H]5C[C@@]54COP(=O)(OCOC(=O)OC(C)C)O[C@@H]2[C@@H]3CO)c(=O)[nH]1.
What is the InChIKey of [(1R,6S,8S,9R,10S,11R,16S,18R,19R)-9-(6-aminopurin-9-yl)-10-hydroxy-19-(hydroxymethyl)-18-(2-methyl-6-oxo-1H-purin-9-yl)-3,13-dioxo-3-(propan-2-yloxycarbonyloxymethoxy)-2,4,12,14,17-pentaoxa-3λ5,13λ5-diphosphatetracyclo[14.2.1.06,8.06,11]nonadecan-13-yl]sulfanylmethyl propan-2-yl carbonate?
The InChIKey is QXRVVMRQZZBBEC-VHFJMBKNSA-N. The full InChI is InChI=1S/C34H45N9O17P2S/c1-15(2)56-32(47)51-13-55-61(49)54-9-34-6-19(34)23(42-11-38-21-27(35)36-10-37-28(21)42)24(45)26(34)60-62(50,63-14-52-33(48)57-16(3)4)53-8-20-18(7-44)25(59-61)31(58-20)43-12-39-22-29(43)40-17(5)41-30(22)46/h10-12,15-16,18-20,23-26,31,44-45H,6-9,13-14H2,1-5H3,(H2,35,36,37)(H,40,41,46)/t18-,19-,20-,23-,24+,25-,26+,31-,34-,61?,62?/m1/s1.
What are the key properties of [(1R,6S,8S,9R,10S,11R,16S,18R,19R)-9-(6-aminopurin-9-yl)-10-hydroxy-19-(hydroxymethyl)-18-(2-methyl-6-oxo-1H-purin-9-yl)-3,13-dioxo-3-(propan-2-yloxycarbonyloxymethoxy)-2,4,12,14,17-pentaoxa-3λ5,13λ5-diphosphatetracyclo[14.2.1.06,8.06,11]nonadecan-13-yl]sulfanylmethyl propan-2-yl carbonate?
[(1R,6S,8S,9R,10S,11R,16S,18R,19R)-9-(6-aminopurin-9-yl)-10-hydroxy-19-(hydroxymethyl)-18-(2-methyl-6-oxo-1H-purin-9-yl)-3,13-dioxo-3-(propan-2-yloxycarbonyloxymethoxy)-2,4,12,14,17-pentaoxa-3λ5,13λ5-diphosphatetracyclo[14.2.1.06,8.06,11]nonadecan-13-yl]sulfanylmethyl propan-2-yl carbonate has a molecular weight of 945.79 g/mol, XLogP of 3.10, 11 rotatable bonds, 4 hydrogen bond donors, and 26 hydrogen bond acceptors.
Where does this data come from?
All data for [(1R,6S,8S,9R,10S,11R,16S,18R,19R)-9-(6-aminopurin-9-yl)-10-hydroxy-19-(hydroxymethyl)-18-(2-methyl-6-oxo-1H-purin-9-yl)-3,13-dioxo-3-(propan-2-yloxycarbonyloxymethoxy)-2,4,12,14,17-pentaoxa-3λ5,13λ5-diphosphatetracyclo[14.2.1.06,8.06,11]nonadecan-13-yl]sulfanylmethyl propan-2-yl carbonate is sourced from PubChem (CID 158858553), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).